January’s top news stories
NIH’s Phase I malaria trial of monoclonal antibody opens enrolment A Phase I clinical trial of monoclonal antibody (mAb) CIS43LS…
Round-up
-
-
November’s top news stories
Lilly and Boehringer begin study of Jardiance in heart failure Eli Lilly and Boehringer Ingelheim started a Phase III clinical…
-
October’s top news stories
GSK initiates Phase III programme of gepotidacin antibiotic GlaxoSmithKline (GSK) initiated the Phase III EAGLE clinical programme of its investigational…
-
August’s top news stories
Retrophin’s fosmetpantotenate fails in Phase III trial for PKAN Biopharmaceutical firm Retrophin reported that the Phase III clinical trial of…
-
June’s top news stories
AstraZeneca reports positive results from CASPIAN trial of Imfinzi AstraZeneca’s human monoclonal antibody Imfinzi (durvalumab) improved overall survival in the…
-
May’s top news stories
Novartis reports positive results from Phase III trial in asthma Novartis reported that the first clinical trial in its Phase…
-
April’s top news stories
I-Mab and MorphoSys begin Phase III study of blood cancer drug Chinese clinical-stage biopharmaceutical company I-Mab Biopharma and German biotech…
-
March’s top news stories
Aldeyra’s ALLEVIATE trial of reproxalap eyedrops meets endpoints Aldeyra Therapeutics reported positive data from the Phase III ALLEVIATE trial that…
-
Deals this week: Voyager Therapeutics, Pulmatrix, Horizon Discovery
Voyager Therapeutics will develop and commercialise Neurocrine Biosciences' gene therapy candidates used to treat severe neurological conditions after a collaboration was…
-
Find out how pharma is fighting respiratory illnesses in the latest Pharma Technology Focus
Pharma Technology Focus is now available on all devices. Read it for free here We look into the safety issues associated…
